Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 328

1.

Response to 'Angiotensin II type 1 and type 2 receptor interplay in hypertension: lesson from a human model of vascular hyporeactivity'.

Schalekamp MA, Danser AH.

J Hypertens. 2013 May;31(5):1056-7. doi: 10.1097/HJH.0b013e32836030f0. No abstract available.

PMID:
23552034
2.

New renin inhibitor VTP-27999 alters renin immunoreactivity and does not unfold prorenin.

Krop M, Lu X, Verdonk K, Schalekamp MA, van Gool JM, McKeever BM, Gregg R, Danser AH.

Hypertension. 2013 May;61(5):1075-82. doi: 10.1161/HYPERTENSIONAHA.111.00967. Epub 2013 Mar 4.

PMID:
23460288
3.

How does the angiotensin II type 1 receptor 'trump' the type 2 receptor in blood pressure control?

Schalekamp MA, Danser AH.

J Hypertens. 2013 Apr;31(4):705-12. doi: 10.1097/HJH.0b013e32835d6d11.

PMID:
23325393
4.

Facilitated diffusion of angiotensin II from perivascular interstitium to AT1 receptors of the arteriole. A regulating step in vasoconstriction.

Schalekamp MA, Danser AH.

J Hypertens. 2011 May;29(5):906-14. doi: 10.1097/HJH.0b013e328344b9a0.

PMID:
21358416
5.

Newly developed renin and prorenin assays and the clinical evaluation of renin inhibitors.

Schalekamp MA, Derkx FH, Deinum J, Danser AJ.

J Hypertens. 2008 May;26(5):928-37. doi: 10.1097/HJH.0b013e3282f6a671. Review.

PMID:
18398335
7.

Angiotensin II production and distribution in the kidney: I. A kinetic model.

Schalekamp MA, Danser AH.

Kidney Int. 2006 May;69(9):1543-52.

8.
9.

Arterial stiffness as the candidate underlying mechanism for postural blood pressure changes and orthostatic hypotension in older adults: the Rotterdam Study.

Mattace-Raso FU, van der Cammen TJ, Knetsch AM, van den Meiracker AH, Schalekamp MA, Hofman A, Witteman JC.

J Hypertens. 2006 Feb;24(2):339-44.

PMID:
16508582
10.

Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study.

Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Breteler MM, Witteman JC.

Circulation. 2006 Feb 7;113(5):657-63.

PMID:
16461838
11.

Moderate alcohol consumption is associated with reduced arterial stiffness in older adults: the Rotterdam study.

Mattace-Raso FU, van der Cammen TJ, van den Elzen AP, Schalekamp MA, Asmar R, Reneman RS, Hoeks AP, Hofman A, Witteman JC.

J Gerontol A Biol Sci Med Sci. 2005 Nov;60(11):1479-83.

PMID:
16339338
12.

Adrenal angiotensin: origin and site of generation.

van Kats JP, Chai W, Duncker DJ, Schalekamp MA, Danser AH.

Am J Hypertens. 2005 Aug;18(8):1104-10.

PMID:
16109325
13.

Blood pressure components and cardiovascular events in older adults: the Rotterdam study.

Mattace-Raso FU, van der Cammen TJ, van Popele NM, van der Kuip DA, Schalekamp MA, Hofman A, Breteler MM, Witteman JC.

J Am Geriatr Soc. 2004 Sep;52(9):1538-42.

PMID:
15341558
14.

C-reactive protein and arterial stiffness in older adults: the Rotterdam Study.

Mattace-Raso FU, van der Cammen TJ, van der Meer IM, Schalekamp MA, Asmar R, Hofman A, Witteman JC.

Atherosclerosis. 2004 Sep;176(1):111-6.

PMID:
15306182
15.

Angiotensin-converting enzyme gene polymorphism and common carotid stiffness. The Rotterdam study.

Mattace-Raso FU, van der Cammen TJ, Sayed-Tabatabaei FA, van Popele NM, Asmar R, Schalekamp MA, Hofman A, van Duijn CM, Witteman JC.

Atherosclerosis. 2004 May;174(1):121-6.

PMID:
15135260
16.

Intima-media thickness of the common carotid arteries is related to coronary atherosclerosis and left ventricular hypertrophy in older adults.

Mattace-Raso F, van Popele NM, Schalekamp MA, van der Cammen TJ.

Angiology. 2002 Sep-Oct;53(5):569-74.

PMID:
12365865
17.

Functional effects of renal artery stent placement on treated and contralateral kidneys.

Leertouwer TC, Derkx FH, Pattynama PM, Deinum J, van Dijk LC, Schalekamp MA.

Kidney Int. 2002 Aug;62(2):574-9.

18.

Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II.

Saris JJ, van den Eijnden MM, Lamers JM, Saxena PR, Schalekamp MA, Danser AH.

Hypertension. 2002 Feb;39(2 Pt 2):573-7.

PMID:
11882610
19.

Vasoconstriction is determined by interstitial rather than circulating angiotensin II.

Schuijt MP, de Vries R, Saxena PR, Schalekamp MA, Danser AH.

Br J Pharmacol. 2002 Jan;135(1):275-83.

20.

Intrarenal angiotensin II: interstitial and cellular levels and site of production.

van Kats JP, Schalekamp MA, Verdouw PD, Duncker DJ, Danser AH.

Kidney Int. 2001 Dec;60(6):2311-7.

21.

Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens.

van Jaarsveld BC, Krijnen P, Derkx FH, Deinum J, Woittiez AJ, Postma CT, Schalekamp MA.

J Hum Hypertens. 2001 Oct;15(10):669-76.

22.

Prorenin accumulation and activation in human endothelial cells: importance of mannose 6-phosphate receptors.

van den Eijnden MM, Saris JJ, de Bruin RJ, de Wit E, Sluiter W, Reudelhuber TL, Schalekamp MA, Derkx FH, Danser AH.

Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):911-6.

PMID:
11397696
23.

Angiotensin converting enzyme is the main contributor to angiotensin I-II conversion in the interstitium of the isolated perfused rat heart.

de Lannoy LM, Schuijt MP, Saxena PR, Schalekamp MA, Danser AH.

J Hypertens. 2001 May;19(5):959-65.

PMID:
11393680
24.

Subcellular localization of angiotensin II in kidney and adrenal.

van Kats JP, van Meegen JR, Verdouw PD, Duncker DJ, Schalekamp MA, Danser AH.

J Hypertens. 2001 Mar;19(3 Pt 2):583-9.

PMID:
11327633
25.

High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin.

Saris JJ, Derkx FH, De Bruin RJ, Dekkers DH, Lamers JM, Saxena PR, Schalekamp MA, Jan Danser AH.

Am J Physiol Heart Circ Physiol. 2001 Apr;280(4):H1706-15.

26.

Cardiomyocytes bind and activate native human prorenin : role of soluble mannose 6-phosphate receptors.

Saris JJ, Derkx FH, Lamers JM, Saxena PR, Schalekamp MA, Danser AH.

Hypertension. 2001 Feb;37(2 Pt 2):710-5.

PMID:
11230361
27.

Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II.

van Kats JP, Duncker DJ, Haitsma DB, Schuijt MP, Niebuur R, Stubenitsky R, Boomsma F, Schalekamp MA, Verdouw PD, Danser AH.

Circulation. 2000 Sep 26;102(13):1556-63.

PMID:
11004147
28.

The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group.

van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT, Dees A, Woittiez AJ, Bartelink AK, Man in 't Veld AJ, Schalekamp MA.

N Engl J Med. 2000 Apr 6;342(14):1007-14.

29.

Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm.

Saris JJ, van Dijk MA, Kroon I, Schalekamp MA, Danser AH.

Hypertension. 2000 Mar;35(3):764-8.

PMID:
10720592
30.

Cardiac interstitial fluid levels of angiotensin I and II in the pig.

Schuijt MP, van Kats JP, de Zeeuw S, Duncker DJ, Verdouw PD, Schalekamp MA, Danser AH.

J Hypertens. 1999 Dec;17(12 Pt 2):1885-91.

PMID:
10703885
31.

Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism.

Danser AH, Deinum J, Osterop AP, Admiraal PJ, Schalekamp MA.

J Hypertens. 1999 Dec;17(12 Pt 2):1867-72.

PMID:
10703882
32.

Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase.

MaassenVanDenBrink A, de Vries R, Saxena PR, Schalekamp MA, Danser AH.

Cardiovasc Res. 1999 Nov;44(2):407-15.

PMID:
10690317
33.

Inter-observer variability in the angiographic assessment of renal artery stenosis. DRASTIC study group. Dutch Renal Artery Stenosis Intervention Cooperative.

van Jaarsveld BC, Pieterman H, van Dijk LC, van Seijen AJ, Krijnen P, Derkx FH, Man in't Veld AJ, Schalekamp MA.

J Hypertens. 1999 Dec;17(12 Pt 1):1731-6.

PMID:
10658939
34.

Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II.

van Kesteren CA, Saris JJ, Dekkers DH, Lamers JM, Saxena PR, Schalekamp MA, Danser AH.

Cardiovasc Res. 1999 Jul;43(1):148-56.

PMID:
10536699
35.

Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus.

Deinum J, Rønn B, Mathiesen E, Derkx FH, Hop WC, Schalekamp MA.

Diabetologia. 1999 Aug;42(8):1006-10. Erratum in: Diabetologia 1999 Dec;42(12):1444.

PMID:
10491762
36.

Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy.

Deinum J, Tarnow L, van Gool JM, de Bruin RA, Derkx FH, Schalekamp MA, Parving HH.

Nephrol Dial Transplant. 1999 Aug;14(8):1904-11.

PMID:
10462269
37.

Uptake and proteolytic activation of prorenin by cultured human endothelial cells.

Admiraal PJ, van Kesteren CA, Danser AH, Derkx FH, Sluiter W, Schalekamp MA.

J Hypertens. 1999 May;17(5):621-9.

PMID:
10403605
38.

Improved immunoradiometric assay for plasma renin.

Deinum J, Derkx FH, Schalekamp MA.

Clin Chem. 1999 Jun;45(6 Pt 1):847-54.

39.

Angiotensin I-to-II conversion in the human renal vascular bed.

Danser AH, Admiraal PJ, Derkx FH, Schalekamp MA.

J Hypertens. 1998 Dec;16(12 Pt 2):2051-6.

PMID:
9886896
40.

Probing epitopes on human prorenin during its proteolytic and non-proteolytic activation.

Deinum J, Derkx FH, Schalekamp MA.

Biochim Biophys Acta. 1998 Nov 10;1388(2):386-96.

PMID:
9858773
41.

Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME.

Broere A, Van Den Meiracker AH, Boomsma F, Derkx FH, Veld AJ, Schalekamp MA.

Am J Physiol. 1998 Dec;275(6):F870-7. doi: 10.1152/ajprenal.1998.275.6.F870.

PMID:
9843903
42.

A clinical prediction rule for renal artery stenosis.

Krijnen P, van Jaarsveld BC, Steyerberg EW, Man in 't Veld AJ, Schalekamp MA, Habbema JD.

Ann Intern Med. 1998 Nov 1;129(9):705-11.

PMID:
9841602
43.

AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy.

Osterop AP, Kofflard MJ, Sandkuijl LA, ten Cate FJ, Krams R, Schalekamp MA, Danser AH.

Hypertension. 1998 Nov;32(5):825-30.

PMID:
9822439
44.

Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions.

van Kats JP, Danser AH, van Meegen JR, Sassen LM, Verdouw PD, Schalekamp MA.

Circulation. 1998 Jul 7;98(1):73-81.

PMID:
9665063
45.

Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans.

Danser AH, Derkx FH, Schalekamp MA, Hense HW, Riegger GA, Schunkert H.

J Hypertens. 1998 Jun;16(6):853-62.

PMID:
9663926
46.

Continuous arterio-venous haemodiafiltration: hydraulic and diffusive permeability index of an AN-69 capillary haemofilter.

Akcahuseyin E, van Duyl WA, Vincent HH, Vos MC, Schalekamp MA.

Med Biol Eng Comput. 1998 Jan;36(1):43-50.

PMID:
9614747
47.

Localization and production of angiotensin II in the isolated perfused rat heart.

de Lannoy LM, Danser AH, Bouhuizen AM, Saxena PR, Schalekamp MA.

Hypertension. 1998 May;31(5):1111-7.

PMID:
9576122
48.

Angiotensin-converting enzyme inhibition does not correct early defects in renal and vascular permeability in diabetes mellitus.

Zietse R, Derkx FH, Weimar W, Schalekamp MA.

Clin Sci (Lond). 1998 Feb;94(2):165-73.

PMID:
9536925
49.

Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells.

van Kesteren CA, Danser AH, Derkx FH, Dekkers DH, Lamers JM, Saxena PR, Schalekamp MA.

Hypertension. 1997 Dec;30(6):1389-96.

PMID:
9403558
50.

Evidence for the existence of a functional cardiac renin-angiotensin system in humans.

Danser AH, van Kats JP, Verdouw PD, Schalekamp MA.

Circulation. 1997 Nov 18;96(10):3795-6. No abstract available.

PMID:
9396499

Supplemental Content

Loading ...
Support Center